Table 4 Characteristics of primary tumors and matched lymph node metastases with HER2 heterogeneous expression

From: Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibility

Case

 

Histological variant

Homogeneity for HER2 IHC score

HER2 membrane staining intensity

FISH

#1

T

Squamous differentiation

Heterogeneous

Absent

Negative

T

Micropapillary

 

Moderate

Positive

LN

Conventional

Heterogeneous

Weak

Equivocal

LN

Micropapillary

 

Moderate

Positive

#2

T

Conventional

Heterogeneous

Weak

Negative

T

Glandular differentiation

 

Moderate

Positive

LN

Conventional

Homogeneous

Moderate

Equivocal

LN

Micropapillary

 

Moderate

Equivocal

#3

T

Conventional

Homogeneous

Moderate

Negative

T

Micropapillary

 

Moderate

Negative

LN

Conventional

Heterogeneous

Weak

Negative

LN

Micropapillary

 

Moderate

Equivocal

#4

T

Conventional

Heterogeneous

Weak

Negative

T

Conventional

 

Moderate

Equivocal

LN

Squamous differentiation

Heterogeneous

Weak

NC

LN

Squamous differentiation

 

Moderate

NC

#5

T

Conventional

Heterogeneous

Weak

Negative

T

Micropapillary

 

Moderate

Negative

LN

Conventional

Homogeneous

Moderate

Negative

LN

Micropapillary

 

Moderate

Negative

#6

T

Conventional

Homogeneous

Weak

NC

T

Micropapillary

 

Weak

NC

LN

Conventional

Heterogeneous

Weak

Negative

LN

Micropapillary

 

Moderate

Positive

#7

T

Squamous differentiation

Heterogeneous

Weak

Negative

T

Micropapillary

 

Strong

Positive

#8

T

Conventional

Heterogeneous

Weak

Negative

T

Micropapillary

 

Strong

Equivocal

LN

Micropapillary

Homogeneous

Moderate

NC

#9

T

Conventional

Heterogeneous

Weak

Negative

T

Micropapillary

 

Moderate

Negative

#10

T

Conventional

Heterogeneous

Absent

Negative

T

Conventional

 

Moderate

Negative

#11

T

Conventional

Heterogeneous

Absent

Negative

T

Plasmacytoid

 

Moderate

Equivocal

LN

Conventional

Homogeneous

Moderate

NC

#12

T

Sarcomatoid

Heterogeneous

Absent

Negative

T

Squamous differentiation

 

Moderate

Positive

LN

Sarcomatoid

Homogeneous

Moderate

Negative

LN

Squamous differentiation

 

Moderate

Negative

#13

T

Conventional

Homogeneous

Moderate

Equivocal*

LN

Conventional with extra capsular extension

Heterogeneous

Weak

Equivocal**

LN

Conventional carcinoma within sinuses

 

Moderate

Equivocal***

  1. Only cases with at least one sample with contributive FISH are reported
  2. #13, equivocal HER2/CEP17 ratio = *1.62, **1.77, ***1.96
  3. FISH fluorescent in situ hybridization, HER2 human epidermal growth factor receptor 2, IHC immunohistochemistry, LN lymph node metastases, NC non-contributive, T primary tumor